http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106148537-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106148537-B |
| titleOfInvention | One kind serum relevant to diabetes B or blood plasma miRNA marker and its application |
| abstract | The invention discloses a kind of serum relevant to diabetes B or blood plasma miRNA marker and its applications.The invention also discloses a kind of diabetes B diagnostic kits.Marker of the invention diagnoses the risk that Obese children early warning long term insulin resistance and diabetes B occur from microcosmic angle, and it is easy to operate, as a result accurate objective is reliable, diabetes B group and Metabolism of Normal group can be distinguished well, it can be accurate, the risk that sensitive assessment and early warning Obese children long term insulin resistance and diabetes B occur, only need offer blood sample that can carry out, without other tissue samples, a possibility that substantially increasing clinical application and feasibility, for clinicians make early prevention, foundation is instructed in intervention stratege and judging prognosis offer. |
| priorityDate | 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 165.